Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of the PECS II block on postoperative pain and opioid demand in patients undergoing minimally invasive cardiac surgery
2021-005452-11Phase 4Completed
- Sponsor
- Medical University of Innsbruck
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine in postoperative pain, sponsored by Medical University of Innsbruck. Primary endpoint: Total opioid consumption in the first 24 hours. Started Nov 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2021-005452-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-005452-11.